Brief: ORIC Pharmaceuticals Q4 Net Income USD -30.505 Million
23/02/2026 21:05
Feb 23 (Reuters) - ORIC Pharmaceuticals Q4 operating expenses USD 34.551 million. Q4 income from operations USD -34.551 million
Recent news on ORIC Pharmaceuticals
See all newsBrief: Oric® Pharmaceuticals Announces Agreement With Cancer Research UK
ORIC Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: ORIC Pharmaceuticals Q1 Operating Expenses USD 39.619 Million
Brief: Oric Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ORIC Pharmaceuticals Q4 loss narrows